Release Date: 21/12/23 15:29 Summary: US SEC Filing - Statement of Additional Information Price Sensitive: No Download Document 113.3KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling